Completed

 Limit: 1 // R. Schomer (School of Plant Sciences)

Institutions may submit one nominee to the New Innovator Award program.

*Deadline note: This selection process is running with an anticipated deadline. We will inform all applicants of relevant updates in the guidelines, submission deadlines, and eligibility as soon as more information becomes available.

The Foundation for Food and Agriculture Research (FFAR)  New Innovator Program,  will allow investigators to explore new avenues of inquiry that arise during their research. Therefore, FFAR is interested in the program of research to be explored and its impact as opposed to a list of very specific aims. The review process emphasizes the individual’s creativity, the innovativeness of the research approaches, and the potential of the program; collaborations are encouraged. While this award is made to an outstanding early career investigator, applicants should include information regarding any essential collaborators and include letters of support from those collaborators. Each applicant can receive from FFAR up to $150,000 per year for a maximum of three years totaling $450,000 investment.

Research programs should fall within one of FFAR’s Challenge Areas

• Advanced Animal Systems
• Health-Agriculture Nexus
• Next Generation Crops
• Soil Health
• Sustainable Water Management
• Urban Food Systems
•  Climate change  

No Applicants // Limit: 1 // Tickets Available: 1

Only one application per institution (normally identified by having a unique entity identifier [UEI] number) is allowed. 

This Notice of Funding Opportunity (NOFO) is designed to understand the feasibility and acceptability of providing long-acting injectable antiretroviral therapy (LAI-ART) to incarcerated persons with HIV who are soon to be released from state prison facilities. The ultimate goal is to support the development and implementation of effective, sustainable, replicable LAI-ART programs. People with HIV living in prison facilities are often released to the community lacking support for ongoing HIV care. There is a paucity of programs for this population demonstrating effectiveness with retention in care and maintaining sustained HIV viral suppression after release. The use of LAI-ART prior to and at the time of release from prison may improve adherence to HIV treatment, retention in care, and maintenance of viral load suppression among persons reentering the community. Applied qualitative and quantitative research resulting from this funding is expected to strengthen adherence to ART and is aligned with the HIV National Strategic Plan (2022-2025) and the Ending the HIV Epidemic in the U.S. (EHE) initiative “Treat” Pillar.

Limit: 2 // Tickets Available: 1

 H-J. Kim (Civil Engineering)

Institutions can receive only two awards each year and can submit a limit of two applications per year.
*The ORAU Innovation Partnerships Grant Program is a single fiscal year award for events held between September 1, 2023 and September 30, 2024.

Event or conference sponsorship is often beneficial to the Oak Ridge Associated Universities (ORAU) Council of Sponsoring Institution Members, whether as a means of fostering collaboration among Council members, gaining new and important information for a proposal or business plan, and more. Up to $4,000 may be requested to support an in-person or virtual event that involves participants from more than one ORAU member institution, including students. Innovation Partnership applications should focus on focused workshops/conferences that highlight your university’s strategic STEM research and education growth areas, and where collaborations with other member universities would add value. We are specifically interested in events that can bring more thought leadership in building a national strategy for STEM education and workforce development. Member universities are encouraged to collaborate around this topic in anticipation of federal funding initiatives. 

FY 2024 Innovation Partnerships Grant Focus Areas:

• Climate and Environment - sustainability, environmental justice, clean energy, resilience to climate hazards, emerging technologies, measurement and impact assessment, diversity and inclusion, policy, and data science and analytics
• Health Equity - telemedicine, telehealth, health literacy, health communication, behavioral and mental health, health disparities, diversity and inclusion, policy, and data science and analytics
• Future of the STEM Workforce - new ways of teaching and learning (K-16), transformative workforce capacity building and mentoring, diversity and inclusion, policy, data science, machine learning, and artificial intelligence

 Limit: 1 // PIs: B. Eckert & D. Axon (College of Pharmacy)

In general, multiple applications associated with the same DUNS number and/or Employee Identification Number (EIN) are not allowable. However, HRSA recognizes a growing trend towards greater consolidation within the rural health care industry and the possibility that multiple health care organizations may share the same EIN as its parent organization. 

The Health Resources and Services Administration (HRSA) is accepting applications for the fiscal year (FY) 2024 Rural Health Network Development Planning Program. The purpose of this program is to promote the planning and development of integrated health care networks to address the following legislative aims: (i) achieve efficiencies; (ii) expand access to, coordinate, and improve the quality of basic health care services and associated health outcomes; and (iii) strengthen the rural health care system as a whole. 

No Applicants // Limit: 1 // Tickets Available: 1 

The foundation will consider more than one application per institution per year, but only one application per laboratory/mentor per year.

The Lalor Foundation postdoctoral fellowship program supports promising new researchers in establishing scientific and teaching careers. The program’s mission is to support these researchers early in their work so that they can become independently funded in the field of mammalian reproductive biology as related to the regulation of fertility. The Lalor Foundation will award fellows $55,000 per year to cover a fellowship stipend, fringes, and institutional overhead. Other expenses are not allowed. Institutional overhead may not exceed 10 percent of the total fellowship award. Renewal for one additional year is possible; please refer to specific renewal information under Application Instructions. 

 Limit: 4 //

M. Verhougstraete (Community, Environment & Policy)
J. Schroeder (Molecular and Cellular Biology)
H. Cai (Neuroscience)
J. Bibb (Translational Neurosciences)
 

The mission of The G. Harold and Leila Y. Mathers Foundation is to advance knowledge in the life sciences by sponsoring scientific research that will benefit mankind. The foundation’s grants program seeks to support basic science, ideally with potential translational applications. Immunology, microbiome, genomics, structural biology, cellular physiology, neuroscience, etc., are some noteworthy examples of current research support. 

For many years the Foundation has enjoyed special recognition in the research community for supporting “basic” scientific research, realizing that true transformative breakthroughs usually occur after a thorough understanding of the fundamental mechanisms underlying natural phenomena. More recently, and with the advent of newer investigative methodologies, technology, and tools, the Foundation now embraces innovative translational research proposals.

The grant duration must be three years. The budget should be reasonable based on the aims of the project. Indirect costs may not exceed 10%. Preliminary Budgets are required during the LOI phase. A detailed budget justification is not required until the proposal phase.  The Foundation’s grant award is not intended to be utilized for purchasing capital equipment (“bricks-and-mortar”) for the lab and is intended only to support the actual investigation. The Foundation assumes and expects that capital equipment must be provided by the research institution or university.
 

Application Guidance:

• Grant budgets cannot exceed $600-750K 
• The Foundation primarily supports basic science, ideally with potential translational applications.
• Immunology, microbiome, genomics, structural biology, cellular physiology, neuroscience, etc., are some noteworthy examples of current research support.
• Covid-19-related research projects (aims or sub-aims) will not be considered for support.
• Medical imaging technology-related projects and/or electrical engineering technology development projects will not be considered for support.
• Plant Biology Research, Oceanography, Space Exploration. and Global warming-related research will not be considered for support.
• As technology continues to advance, it is apparent that investigations in the area of basic science and translational research may become more and more reliant on collaborative, interdisciplinary projects. It is important to note that any interdisciplinary project proposals may require additional information regarding the collaborator(s)’ achievements and relevant expertise.
• Feedback for declined LOI Requests will not be provided; LOIs or Formal Proposals that have been declined should not be resubmitted at a later date for consideration.
• Renewal applications for the same or related research will not be accorded priority consideration. It is strongly advised that any re-application for grant renewal consider a new direction based on prior research or emphasize some new potential translational aspects and not merely an extension of previously funded research.
• Requests for funding previously federally supported research and/or applications pending federal approval will not be accorded priority consideration.
• Requests for support of clinical trials or drug discovery will not be approved. The Foundation will not support projects which we consider pre-clinical drug development.

No Applicants  // Limit: 2 // Tickets Available: 2 

Applicant institutions are limited to no more than two pre-applications or applications as the lead institution for each PI at the applicant institution.

The DOE SC program in Fusion Energy Sciences (FES) hereby announces its interest in receiving applications to carry out experimental research in magnetic fusion energy sciences on long-pulse overseas stellarator facilities, namely, Wendelstein 7-X (W7-X – Germany) and the Large Helical Device (LHD – Japan). The research should be related to the planning, execution, and analysis of experiments concerning the topical areas described below. The FES Burning Plasma Science: Long Pulse portfolio supports U.S. researchers who work in collaboration with foreign scientists to explore critical science and technology issues at the frontiers of magnetic fusion research. These collaborations take advantage of the unique capabilities of the most advanced overseas research facilities.

Submit ticket request  // Limit: 1 // Tickets Available: 1 

NIFA requests applications for the ARME for fiscal year (FY) 2024 to provide resources for four regional risk management education centers for the purpose of developing and delivering agricultural risk managementeducation materials. In addition, this program will provide one grant for a Risk Management Education Electronic Support Center to provide associated support to the regional centers.

The primary goals and objectives of the ARME program are to 1) provide U.S. agricultural producers and their families, as appropriate, with the knowledge, skills, and tools needed to make informed risk management decisions that enhance profitability of their operations, and 2) deliver risk management education to agricultural producers underserved by the Federal crop insurance program. 

No applicants  // Limit: 1 // Tickets Available: 1 

The Health Resources and Services Administration (HRSA) is accepting applications for fiscal year (FY) 2019 Healthy Start Initiative: Eliminating Disparities in Perinatal Health. The purpose of this Healthy Start (HS)program is to improve health outcomes before, during, and after pregnancy, and reduce racial/ethnic differences in rates of infant death and adverse perinatal outcomes. 

HS has two focus areas: 1) providing direct and enabling services (for example, screening and referrals, case management and care coordination, health and parenting education, and linkage to clinical care) to enrolled HS participants; and 2) convening Community Consortia (formerly known as Community Action Networks or “CANs”) comprised of diverse, multi-sector partners to advise and inform HS activities as well as to develop and implement plans to improve perinatal outcomes within the selected project area. HS continues to have an increased emphasis on addressing social determinants of health, such as access to adequate food, housing, and transportation, to improve disparities in maternal and infant health outcomes. Based on stakeholder feedback, this FY 2024 HS competition also provides recipients with increased flexibility to tailor interventions to the unique needs of their community and/or target population.

The goals of HS are to:

1) Continue reducing infant mortality rates in the United States, and

2) Decrease disparities in infant mortality and poor perinatal health outcomes in areas where those rates are high.

No Applicants  // Limit: 1 // Tickets Available: 1 

The APECx program aims to create a toolkit to enable accurate chimeric and broadly efficacious vaccine Ag discovery through predictive modeling, high-throughput functional experimentation, and protein engineering. To fundamentally transform the vaccine research and development (R&D) sector, APECx will develop an innovative viral Ag prediction pipeline for broad efficacy by combining expedited experimental protein structure and function determination with high-throughput Ag screening. This will be enhanced with structural and functional prediction and protein modeling algorithms. Product developers will contribute to modeling tool evaluation from the start of the program to ensure discoveries satisfy the translational requirements. The combined effort of all the teams will create a toolkit that will enable the U.S. to achieve genus-level vaccine goals and prevent multiple viral diseases, including those responsible for cancer, acute disease, and chronic illness across the country and the world.